Detalles de la búsqueda
1.
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo.
J Antimicrob Chemother;
78(4): 946-952, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36760083
2.
Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection.
J Antimicrob Chemother;
76(1): 189-198, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33035324
3.
Utility of Coproporphyrin-I Determination in First-in-Human Study for Early Evaluation of OATP1B Inhibitory Potential Based on Investigation of Ensitrelvir, an Oral SARS-CoV-2 3C-Like Protease Inhibitor.
J Pharm Sci;
113(3): 798-805, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37742997
4.
Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies.
J Clin Pharmacol;
63(8): 918-927, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043676
5.
In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses.
Viruses;
15(5)2023 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243240
6.
Carryover effects of baloxavir acid in human nasopharyngeal/pharyngeal swabs on infectious titer testing of influenza virus.
Influenza Other Respir Viruses;
14(3): 353-357, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31994309
7.
The antiviral effects of baloxavir marboxil against influenza A virus infection in ferrets.
Influenza Other Respir Viruses;
14(6): 710-719, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533654
Resultados
1 -
7
de 7
1
Próxima >
>>